July 31, 2026

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating Challenges with Innovative Medical Devices

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a notable player in the healthcare sector, is making waves in the medical devices industry. Headquartered in Ponte Vedra, Florida, Treace Medical is renowned..

Rapport Therapeutics, Inc. (RAPP) Stock Report: Analyst Consensus Suggests a 36.95% Upside Potential

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is a clinical-stage biopharmaceutical company making significant waves in the biotechnology industry, particularly in the treatment of central nervous system (CNS) disorders. With its headquarters..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Evaluating a 4.85% Potential Upside Amidst Biotech Ambitions

Theravance Biopharma, Inc. (NASDAQ: TBPH), a prominent player in the biotechnology sector, stands at an intriguing crossroads for investors with its current market cap of $873.31 million. As a biopharmaceutical..

MBX Biosciences, Inc. (MBX) Stock Analysis: Exploring a 20.98% Upside Potential in Biotech Investment

MBX Biosciences, Inc. (MBX), a clinical-stage biopharmaceutical company, is making significant strides in the healthcare sector with a focus on precision peptide therapies. Based in Carmel, Indiana, this innovative biotech..

Auna SA (AUNA) Stock Analysis: Uncovering the 34.6% Potential Upside in Healthcare

Auna SA (AUNA) has emerged as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. With its operations spanning across Mexico, Peru, and Colombia, Auna..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 35% Upside Potential

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the medical technology sector, is drawing investor attention with its promising potential for growth. The company, specializing in innovative solutions for cardiovascular..

Talkspace, Inc. (TALK) Stock Analysis: Exploring a Healthcare Innovator with 18% Revenue Growth and Investor Potential

Investors are increasingly focusing on the healthcare sector, and Talkspace, Inc. (NASDAQ: TALK) has emerged as an intriguing player within the health information services industry. As a digital leader in..

MeiraGTx Holdings plc (MGTX)

⚠️ No article content returned.

..

Kamada Ltd. (KMDA) Stock Analysis: A Healthcare Gem with 83% Upside Potential

Kamada Ltd. (NASDAQ: KMDA), a niche player in the healthcare sector, has captured investor attention with its robust portfolio of plasma-derived protein therapeutics and a compelling growth narrative. Based in..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Promising Biotech with a 10% Potential Upside and Strong Buy Ratings

Sionna Therapeutics, Inc. (NASDAQ: SION) is rapidly capturing the attention of investors in the biotechnology sector. With a market capitalization of $2.11 billion, this clinical-stage biopharmaceutical company is making significant..

Vir Biotechnology, Inc. (VIR) Stock Analysis: A 142% Upside Potential Amidst Biotech Innovation

Investors with an appetite for high potential gains in the healthcare sector might want to keep a close watch on Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage biopharmaceutical company based..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a Potential 90.71% Upside

Investors seeking high-growth opportunities in the biotechnology sector might find Nuvation Bio Inc. (NASDAQ: NUVB) to be an intriguing prospect. With a market capitalization of $2.33 billion, this clinical-stage biopharmaceutical..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A 51% Upside Potential in the Biotech Arena

Oruka Therapeutics, Inc. (NASDAQ: ORKA), a clinical-stage biopharmaceutical company based in Menlo Park, California, is capturing the attention of investors with its innovative approach to treating inflammatory and immunological conditions...

Cel-Sci Corporation (CVM) Stock Analysis: Could a 1,129% Upside Be on the Horizon?

For investors with a keen eye on the biotechnology sector, Cel-Sci Corporation (NASDAQ: CVM) presents a compelling yet high-risk opportunity that merits attention. With a market capitalization of $21.32 million..

Precigen, Inc. (PGEN) Investor Outlook: Exploring a Promising 110% Upside in Biotech

Precigen, Inc. (NASDAQ: PGEN), a trailblazer in the biotechnology sector, has been catching the eye of investors with its impressive potential upside, estimated at 110.44%. With a market capitalization of..

LifeMD, Inc. (LFMD) Stock Analysis: Massive 171% Upside Potential Offers Compelling Growth Prospects

LifeMD, Inc. (NASDAQ: LFMD), a pioneering player in the healthcare sector, is capturing investor attention with its potential for significant upside. Operating as a direct-to-patient telehealth company, LifeMD provides virtual..

Septerna, Inc. (SEPN) Stock Analysis: Insights into a Biotech with 27.91% Upside Potential

Investors seeking growth opportunities in the biotechnology sector should consider the promising outlook of Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotech firm with a robust pipeline and significant potential upside...

GH Research PLC (GHRS) Stock Analysis: Biotech Firm’s Bold Leap with 40.94% Potential Upside

GH Research PLC (NASDAQ: GHRS), an emerging player in the biotechnology sector, is garnering significant attention from investors, particularly due to its robust potential upside of 40.94%. This Dublin-based clinical-stage..

Verastem, Inc. (VSTM) Stock Analysis: Exploring a Potential 145.90% Upside in Biotech Innovation

Investors with a keen eye on the biotechnology sector may find Verastem, Inc. (VSTM) an intriguing prospect. This development-stage biopharmaceutical company, headquartered in Needham, Massachusetts, is making strides in the..

Fulgent Genetics, Inc. (FLGT): Investor Outlook Amidst Challenging Valuation Metrics

Fulgent Genetics, Inc. (NASDAQ: FLGT), a notable player in the healthcare sector specializing in diagnostics and research, has been garnering attention for its innovative clinical diagnostic and therapeutic solutions. Despite..

Search

Funds

July 31, 2026

Search

Funds

July 31, 2026

FTSE 100

Funds